Evidence map›Paper›PMID 29699579›Full record

ArticleCritical care (London, England)2018

Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery.

Jian-Jhong Wang, Nai-Hsin Chi, Tao-Min Huang, Rory Connolly, Liang Wen Chen, Shih-Chieh Jeff Chueh, Wei-Chih Kan, Chih-Cheng Lai, Vin-Cent Wu, Ji-Tseng Fang and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Article
  7. Article
  8. Article
  9. Article
  10. [Artificial intelligence and acute kidney injury].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jian-Jhong WangDivision of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Nai-Hsin ChiDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Tao-Min HuangNSARF group (National Taiwan University Hospital Study Group of ARF), Taipei, Taiwan.
Rory ConnollySchool of Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Liang Wen ChenDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Shih-Chieh Jeff ChuehCleveland Clinic Lerner College of Medicine and Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA.
Wei-Chih KanDivision of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Chih-Cheng LaiDepartment of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Vin-Cent WuNSARF group (National Taiwan University Hospital Study Group of ARF), Taipei, Taiwan. q91421028@ntu.edu.tw.
Ji-Tseng FangChang Gung University College of Medicine, Taoyuan, Taiwan.
Tzong-Shinn ChuNSARF group (National Taiwan University Hospital Study Group of ARF), Taipei, Taiwan.
Kwan-Dun WuNSARF group (National Taiwan University Hospital Study Group of ARF), Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) after cardiovascular surgery is a serious complication. Little is known about the ability of novel biomarkers in combination with clinical risk scores for prediction of advanced AKI.

methodsIn this prospectively conducted multicenter study, urine samples were collected from 149 adults at 0, 3, 6, 12 and 24 h after cardiovascular surgery. We measured urinary hemojuvelin (uHJV), kidney injury molecule-1 (uKIM-1), neutrophil gelatinase-associated lipocalin (uNGAL), α-glutathione S-transferase (uα-GST) and π-glutathione S-transferase (uπ-GST). The primary outcome was advanced AKI, under the definition of Kidney Disease: Improving Global Outcomes (KDIGO) stage 2, 3 and composite outcomes were KDIGO stage 2, 3 or 90-day mortality after hospital discharge.

resultsPatients with advanced AKI had significantly higher levels of uHJV and uKIM-1 at 3, 6 and 12 h after surgery. When normalized by urinary creatinine level, uKIM-1 in combination with uHJV at 3 h post-surgery had a high predictive ability for advanced AKI and composite outcome (AUC = 0.898 and 0.905, respectively). The combination of this biomarker panel (normalized uKIM-1, uHJV at 3 h post-operation) and Liano's score was superior in predicting advanced AKI (AUC = 0.931, category-free net reclassification improvement of 1.149, and p <  0.001).

conclusionsWhen added to Liano's score, normalized uHJV and uKIM-1 levels at 3 h after cardiovascular surgery enhanced the identification of patients at higher risk of progression to advanced AKI and composite outcomes.

Indexed as

Acute Kidney InjuryAdultAgedAnalysis of VarianceBiomarkersCardiac Surgical ProceduresChi-Square DistributionFemaleGlutathione S-Transferase piGlutathione TransferaseGPI-Linked ProteinsHemochromatosis ProteinHepatitis A Virus Cellular Receptor 1Hospital MortalityHumansIntensive Care UnitsBiomarkersglutathione S-transferase alphaGlutathione S-Transferase piGlutathione TransferaseGPI-Linked ProteinsHAVCR1 protein, humanHemochromatosis ProteinHepatitis A Virus Cellular Receptor 1HJV protein, humanIsoenzymesLipocalin-2Acute kidney injuryBiomarkersHemojuvelinKidney injury molecule-1Liano’s scoreNeutrophil gelatinase-associated lipocalinα-Glutathione S-transferaseπ-Glutathione S-transferase

Identifiers

PMID29699579
PMCPMC5921971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.